购物车
- 全部删除
- 您的购物车当前为空
4EGI-1 是一种竞争性 eIF4E/eIF4 g 相互作用抑制剂,与 eIF4E 结合,Kd 值为 25 μM。
4EGI-1 是一种竞争性 eIF4E/eIF4 g 相互作用抑制剂,与 eIF4E 结合,Kd 值为 25 μM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 313 | 现货 | |
2 mg | ¥ 445 | 现货 | |
5 mg | ¥ 795 | 现货 | |
10 mg | ¥ 995 | 现货 | |
25 mg | ¥ 1,990 | 现货 | |
50 mg | ¥ 2,890 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 866 | 现货 |
产品描述 | 4EGI-1, a competitive eIF4E/eIF4 g interaction inhibitor, binds to eIF4E(KD=25 μM). |
靶点活性 | eIF4E-eIF4G:25 μM(Kd) |
体内活性 | 在Jurkat细胞中,4EGI-1能够促进细胞凋亡。在A549肺癌细胞中(IC50=6 μM),4EGI-1能够有效抑制细胞生长。在人类肺癌细胞中,4EGI-1通过诱导DR5和下调c-FLIP,cap依赖性蛋白质翻译的抑制而增加TRAIL诱导的细胞凋亡。 |
细胞实验 | Cell viability is measured by treatment of Jurkat cells with compound for 24 h and by determination of intracellular ATP using the CellTiterGlo assay. For measurement of apoptotic DNA fragmentation, cells are treated for 24 h with 60 μM EGI-1 or 6.65 μM camptothecin in the presence or absence of 100 mM zVAD-FMK, a broad-spectrum caspase inhibitor. After fixation and staining with PI, cellular DNA content is determined by FACS analysis in a FACS Calibur machine. Nuclear morphology after 24 h EG1-1 treatment is visualized by staining of cells with Hoechst dye and ?uorescence microscopy. For the A549 lung cancer cells, cell growth in the presence of 4EGI-1 is determined using the SRB staining method.(Only for Reference) |
别名 | 4EGI 1 |
分子量 | 451.28 |
分子式 | C18H12Cl2N4O4S |
CAS No. | 315706-13-9 |
Smiles | OC(=O)C(\Cc1ccccc1[N+]([O-])=O)=N\Nc1nc(cs1)-c1ccc(Cl)c(Cl)c1 |
密度 | 1.58 g/cm3 (Predicted) |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 45.1 mg/mL (100 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容